Search Results
89 results
Your search is now limited to «Merck KGaA» expert search.
BioPharma Dive 03/21/2019 11:50
Darmstadt is roughly 20 miles south of Frankfurt and home to multiple science-based organizations beyond Merck, including the European Space Agency's main mission control and an intergovernmental organization focused on operating meteorological satellites.
More from BioPharma Dive:
WN.com 03/20/2019 14:39
Welcome to Biotech Analysis Central Daily News, a daily news report and analysis about what has happened lately in the biotech industry. AbbVie And Roche Have Trouble With Venclexta As Partial Clinical Hold Is Placed News: Recently, AbbVie (ABBV) and Roche (OTCQX:RHHBY) announced that the FDA had placed a partial clinical hold on Venclexta in all clinical trials dealing with treating patients with blood cancer known as multiple myeloma (MM). Specifically, the reason for the partial clinical hold is because of the data that was looked at from a Phase 3 study known as the BELLINI trial or M14-031. It was noted that a larger portion of relapsed/refractory MM patients treated with the drug had a...
More from WN.com:
Seeking Alpha 03/20/2019 14:14
AbbVie and Roche have trouble with Venclexta as partial clinical hold is placed. Merck KGaA And Pfizer suffer a bad luck streak after latest Bavencio trial Fail.
More from Seeking Alpha:
Zacks.com 03/20/2019 11:30
... n=998) evaluated Bavencio (avelumab) + chemotherapy followed by a maintenance treatment of avelumab + Talzenna versus an active comparator for previously untreated advanced ovarian cancer This is the third avelumab ovarian cancer study failure for Pfizer/Merck KGaA in less than six months.
More from Zacks.com:
FiercePharmaManufacturing 03/20/2019 11:09
Merck today said that the company management and the Joint Works Council at Darmstadt have signed a comprehensive agreement covering the 11,000 employees to secure its “future viability.
More from FiercePharmaManufacturing:
(MENAFN - iCrowdNewsWire) iCrowdNewswire - Mar 20, 2019 Worldwide Drug Discovery Services Market Analysis to 2027 is a specialized and in-depth study of the Drug Discovery Service...
More from Middle East North Africa Financial Network (MENAFN):
PR Newswire 03/19/2019 19:15
The global strategic alliance between Merck KGaA, Darmstadt, Germany , and Pfizer enables the companies to benefit from each other's strengths and capabilities and further explore the therapeutic potential of BAVENCIO, an anti-PD-L1 antibody initially discovered and developed by Merck KGaA ...
More from PR Newswire:
ENDPOINTS 03/19/2019 18:28
Pfizer and Merck KGaA have hit the trifecta for PD-L1 failure in ovarian cancer.
More from ENDPOINTS:
Contract Pharma 03/14/2019 09:49
Merck KGaA has formed a collaboration agreement with Iktos for the use of its generative modelling artificial intelligence (AI) technology, in order to facilitate the rapid and cost-effective discovery and design of promising new compounds.
More from Contract Pharma:
Reuters.com 03/12/2019 12:02
Merck KGaA calls on Versum investors to vote down Entegris merger.
More from Reuters.com:
Business Wire 02/27/2019 14:26
BILLERICA, Mass.--(BUSINESS WIRE)--Entegris, Inc. (NASDAQ:ENTG), a leader in specialty chemicals and advanced materials solutions for the microelectronics industry, today issued the following statement in response to Merck KGaA’s unsolicited offer to acquire Versum Materials, Inc. (NYSE:VSM), a leading specialty materials supplier to the semiconductor industry: "The all-stock merger of equals of Entegris and Versum Materials will create a premier specialty materials company for the semiconducto.

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications